|
CH389134A
(de)
|
1960-03-15 |
1965-03-15 |
Ciba Geigy |
Verfahren zur Herstellung neuer Anthrachinonküpenfarbstoffe
|
|
NL293572A
(https=)
|
1962-06-07 |
|
|
|
|
CH478816A
(de)
|
1965-10-22 |
1969-09-30 |
Ciba Geigy |
Verfahren zur Herstellung neuer N,N'-Di-(pyrimidyl-(4)-aminoalkyl)-diazacycloalkanen
|
|
CH480410A
(de)
|
1967-01-09 |
1969-10-31 |
Geigy Ag J R |
Verfahren zur Herstellung von wasserlöslichen Azopyrimidinfarbstoffen
|
|
CA961052A
(en)
|
1967-01-12 |
1975-01-14 |
Max Schellenbaum |
N-2-ethylhexyl-n'-aryl ureas and preparation containing them
|
|
FR1593586A
(https=)
|
1967-10-17 |
1970-06-01 |
|
|
|
US3608087A
(en)
|
1968-06-21 |
1971-09-21 |
Merck & Co Inc |
Feed compositions
|
|
US3887329A
(en)
|
1969-05-05 |
1975-06-03 |
Ciba Geigy Ag |
Hexamethyl phosphotriamide-dye compositions
|
|
BE756953A
(fr)
|
1969-10-02 |
1971-04-01 |
Merck & Co Inc |
Potentialisation d'antibiotiques
|
|
US3686238A
(en)
|
1970-01-19 |
1972-08-22 |
Syntex Corp |
Glycerol esterified with 2-naphthyl-acetic acids and fatty acids
|
|
US3852434A
(en)
|
1970-09-11 |
1974-12-03 |
Merck & Co Inc |
Potentiation of ({31 ) cis-1,2-epoxypropyl)phosphonic acid and analogues thereof
|
|
US3966744A
(en)
|
1971-01-11 |
1976-06-29 |
Syva Company |
Spin labeled compounds
|
|
US3690834A
(en)
|
1971-01-11 |
1972-09-12 |
Syva Co |
Ligand determination with spin labeled compounds by receptor displacement
|
|
DE2106585A1
(de)
|
1971-02-11 |
1972-08-24 |
Farbenfabriken Bayer Ag, 5090 Leverkusen |
Aminothiodiazole und Thiodiazol-Azofarbstoffe
|
|
CH560197A5
(en)
|
1971-05-17 |
1975-03-27 |
Ciba Geigy Ag |
2-alkylthio-4,6-bis (subst amino)-5-nitropyrimidines - - herbicides
|
|
CH558137A
(de)
|
1971-05-17 |
1975-01-31 |
Ciba Geigy Ag |
Mittel zur beeinflussung des pflanzenwachstums.
|
|
DE2226703A1
(de)
|
1972-05-25 |
1973-12-13 |
Schering Ag |
Neue tetrahydrocarbazolderivate und verfahren zu ihrer herstellung
|
|
US3966764A
(en)
|
1972-07-10 |
1976-06-29 |
Syva Company |
Ligand determination of spin labeled compounds by receptor displacement-amphetamine analogs
|
|
US3849420A
(en)
|
1972-10-20 |
1974-11-19 |
Dow Chemical Co |
Bis-(alkylthio-and alkylsulfonyl)-pentachloroquinolines
|
|
CH574206A5
(https=)
|
1972-11-16 |
1976-04-15 |
Ciba Geigy Ag |
|
|
DE2340569C2
(de)
|
1973-08-10 |
1982-12-02 |
Bayer Ag, 5090 Leverkusen |
Azofarbstoffe
|
|
DE2341925A1
(de)
|
1973-08-20 |
1975-03-06 |
Thomae Gmbh Dr K |
Neue pyrimidinderivate und verfahren zu ihrer herstellung
|
|
AT340933B
(de)
|
1973-08-20 |
1978-01-10 |
Thomae Gmbh Dr K |
Verfahren zur herstellung neuer pyrimidinderivate und ihrer saureadditionssalze
|
|
US4057559A
(en)
|
1973-10-01 |
1977-11-08 |
American Home Products Corporation |
Carbazole acetic acid derivatives
|
|
CH584739A5
(https=)
|
1973-12-21 |
1977-02-15 |
Ciba Geigy Ag |
|
|
US4101541A
(en)
|
1973-12-21 |
1978-07-18 |
Ciba-Geigy Corporation |
3-Cyano-1,2,4-thiadiazolyl-5-czo dyestuffs
|
|
FR2258841B1
(https=)
|
1974-01-29 |
1977-11-04 |
Ugine Kuhlmann |
|
|
AT327605B
(de)
|
1974-05-06 |
1976-02-10 |
Ciba Geigy Ag |
Mittel zur hemmung des pflanzenwachstums
|
|
AU492126B2
(en)
|
1974-05-14 |
1975-11-20 |
Ciba-Geigy Ag |
Nitropyrimidine derivatives
|
|
FR2306697A1
(fr)
|
1975-04-10 |
1976-11-05 |
Sogeras |
Nouvelles pyrimidines utilisables comme medicaments antidiabetiques et hypocholesterolemiants
|
|
US4139705A
(en)
|
1977-05-20 |
1979-02-13 |
The Dow Chemical Company |
Pyrazolopyrimidines
|
|
US4189579A
(en)
|
1977-05-20 |
1980-02-19 |
The Dow Chemical Company |
Aminoalkylthiopurines
|
|
DE2731264A1
(de)
|
1977-07-11 |
1979-02-01 |
Boehringer Mannheim Gmbh |
Neue 1-acyl-2-cyanaziridine, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische zubereitungen
|
|
JPS6038696B2
(ja)
|
1977-12-09 |
1985-09-02 |
コニカ株式会社 |
ハロゲン化銀カラ−写真感光材料
|
|
US4242507A
(en)
|
1978-02-23 |
1980-12-30 |
Fujisawa Pharmaceutical Co., Ltd. |
Sulfonic acid esters
|
|
DE2831580C2
(de)
|
1978-07-18 |
1980-09-18 |
Boehringer Mannheim Gmbh, 6800 Mannheim |
Verfahren und Reagens zur Bestimmung von Glycerin
|
|
DE2831850A1
(de)
|
1978-07-20 |
1980-02-07 |
Basf Ag |
N-arylsulfonylpyrrole, ihre herstellung und diese enthaltende therapeutische mittel
|
|
DE2906603A1
(de)
|
1979-02-21 |
1980-09-04 |
Boehringer Mannheim Gmbh |
N-substituierte aziridin-2-carbonsaeurederivate, verfahren zu deren herstellung sowie diese substanzen enthaltende arzneimittel
|
|
US4343804A
(en)
|
1979-03-26 |
1982-08-10 |
A. H. Robins Company, Inc. |
4-Amino-3-quinolinecarboxylic acids and esters-antisecretory anti-ulcer compounds
|
|
WO1981003174A1
(fr)
|
1980-04-28 |
1981-11-12 |
Teijin Ltd |
Derives de thiazolo (3,2-a) pyrimidine, leur procede de preparation, et medicaments les contenant
|
|
EP0053678A1
(de)
|
1980-12-05 |
1982-06-16 |
BASF Aktiengesellschaft |
5-Amino-1-phenyl-4-cyanpyrazole, diese enthaltende herbizide Mittel, Verfahren zu ihrer Herstellung und ihre Anwendung als Herbizide
|
|
DOP1981004033A
(es)
|
1980-12-23 |
1990-12-29 |
Ciba Geigy Ag |
Procedimiento para proteger plantas de cultivo de la accion fitotoxica de herbicidas.
|
|
DE3334455A1
(de)
|
1983-03-04 |
1984-09-06 |
Bayer Ag, 5090 Leverkusen |
Guanidin - derivate
|
|
US4612376A
(en)
|
1983-03-25 |
1986-09-16 |
Fujisawa Pharmaceutical Co., Ltd. |
Substituted-3,4-dihydro-4-(2,4,6-trimethoxyphenylimino)-2(1H)-pyrimidones useful as cardiotonic, antihypertensive, cerebrovascular vasodilator and anti-platelet agent
|
|
ZA848275B
(en)
|
1983-12-28 |
1985-08-28 |
Degussa |
New piridine-2-ethers or pyridine-2-thioethers having a nitrogen-containing cycloaliphatic ring
|
|
DE3406329A1
(de)
|
1984-02-22 |
1985-08-22 |
Merck Patent Gmbh, 6100 Darmstadt |
Pyridone
|
|
JPS6157587A
(ja)
|
1984-08-29 |
1986-03-24 |
Shionogi & Co Ltd |
縮合複素環誘導体および抗潰瘍剤
|
|
PH22302A
(en)
|
1985-02-11 |
1988-07-22 |
Fujisawa Pharmaceutical Co |
Piperidine compounds
|
|
IE860511L
(en)
|
1985-03-01 |
1986-09-01 |
Alfa Farmaceutici Spa |
"Benzoyl urea derivatives having anti-tumor activity"
|
|
DE3601196A1
(de)
|
1986-01-17 |
1987-07-23 |
Merck Patent Gmbh |
1,4-dihydropyridine
|
|
US4810699A
(en)
|
1987-02-20 |
1989-03-07 |
American Home Products Corporation |
Substituted 1,3,4,9-tetrahydropyrano[3,4,-b]indole-1-acetic acids, pharmaceutical compositions containing them, and methods for treating inflammatory conditions and for analgesic purposes using them
|
|
CA1340284C
(en)
|
1987-03-19 |
1998-12-22 |
Zeneca Inc. |
Herbicidal substituted cyclic diones
|
|
EP0324426B1
(en)
|
1988-01-11 |
1996-06-19 |
Fuji Photo Film Co., Ltd. |
Process for forming super high contrast negative images
|
|
US4782076A
(en)
|
1988-03-01 |
1988-11-01 |
American Home Products Corporation |
Substituted 2,3,4,9-tetrahydro-1H-carbazole-1-acetic acid derivatives, composition and use
|
|
PT95692A
(pt)
|
1989-10-27 |
1991-09-13 |
American Home Prod |
Processo para a preparacao de derivados de acidos indole-,indeno-,piranoindole- e tetra-hidrocarbazole-alcanoicos, ou quais sao uteis como inibidores de pla2 e da lipoxigenase
|
|
NZ238863A
(en)
|
1990-07-19 |
1993-03-26 |
Janssen Pharmaceutica Nv |
Substituted thiazolyl and pyridinyl derivatives
|
|
US5221678A
(en)
|
1990-07-26 |
1993-06-22 |
Merck Frosst Canada, Inc. |
(quinolin-2-ylmethoxy)tetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes
|
|
WO1992012976A1
(fr)
|
1991-01-16 |
1992-08-06 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Compose de pyridine utilise comme medicament selectif et nouveau compose de pyridine
|
|
CA2070978A1
(en)
|
1991-06-11 |
1992-12-12 |
William J. Greenlee |
Cyclic renin inhibitors
|
|
GB9114760D0
(en)
|
1991-07-09 |
1991-08-28 |
Pfizer Ltd |
Therapeutic agents
|
|
JPH0533359A
(ja)
|
1991-08-02 |
1993-02-09 |
Kubota Corp |
全旋回型の小型バツクホウ
|
|
EP0556889A1
(en)
|
1992-02-18 |
1993-08-25 |
Duphar International Research B.V |
Method of preparing aryl(homo)piperazines
|
|
DE4208254A1
(de)
|
1992-03-14 |
1993-09-16 |
Hoechst Ag |
Substituierte pyrimidine, verfahren zu ihrer herstellung und ihre verwendung als schaedlingsbekaempfungsmittel und fungizid
|
|
TW237456B
(https=)
|
1992-04-09 |
1995-01-01 |
Ciba Geigy |
|
|
FR2692575B1
(fr)
|
1992-06-23 |
1995-06-30 |
Sanofi Elf |
Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
|
|
NZ314207A
(en)
|
1992-09-28 |
2000-12-22 |
Vertex Pharma |
1-(2-Oxoacetyl)-piperidine-2-carboxylic acid derivatives as multi drug resistant cancer cell sensitizers
|
|
DE4241632A1
(de)
|
1992-12-10 |
1994-06-16 |
Thomae Gmbh Dr K |
Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
|
TW370529B
(en)
|
1992-12-17 |
1999-09-21 |
Pfizer |
Pyrazolopyrimidines
|
|
US5998499A
(en)
|
1994-03-25 |
1999-12-07 |
Dentsply G.M.B.H. |
Liquid crystalline (meth)acrylate compounds, composition and method
|
|
JPH0753546A
(ja)
|
1993-08-09 |
1995-02-28 |
Kuraray Co Ltd |
ジアリール置換複素環化合物およびその医薬用途
|
|
BR9407799A
(pt)
|
1993-10-12 |
1997-05-06 |
Du Pont Merck Pharma |
Composição de matéria método de tratamento e composição farmaceutica
|
|
GB9400889D0
(en)
|
1994-01-18 |
1994-03-16 |
Sandoz Ltd |
Novel compounds
|
|
TW530047B
(en)
|
1994-06-08 |
2003-05-01 |
Pfizer |
Corticotropin releasing factor antagonists
|
|
PT781766E
(pt)
|
1994-09-09 |
2004-07-30 |
Nippon Shinyaku Co Ltd |
Derivado heterociclico e medicamento
|
|
DE69521529T2
(de)
|
1994-11-29 |
2001-10-11 |
Dainippon Pharmaceutical Co., Ltd. |
Indolderivat
|
|
DE69630214T2
(de)
|
1995-03-10 |
2004-07-15 |
Berlex Laboratories, Inc., Richmond |
Benzamidin-derivate, deren herstellung und deren verwendung als anti-koagulantien
|
|
US5691364A
(en)
|
1995-03-10 |
1997-11-25 |
Berlex Laboratories, Inc. |
Benzamidine derivatives and their use as anti-coagulants
|
|
IL117659A
(en)
|
1995-04-13 |
2000-12-06 |
Dainippon Pharmaceutical Co |
Substituted 2-phenyl pyrimidino amino acetamide derivative process for preparing the same and a pharmaceutical composition containing same
|
|
GB9508538D0
(en)
|
1995-04-27 |
1995-06-14 |
Zeneca Ltd |
Quinazoline derivatives
|
|
WO1996033994A1
(en)
|
1995-04-28 |
1996-10-31 |
Nippon Soda Co., Ltd. |
Amino-substituted derivatives, process for the preparation thereof, and herbicide
|
|
EP0770080B1
(en)
|
1995-05-12 |
1999-07-14 |
Neurogen Corporation |
Novel deazapurine derivatives; a new class of crf1 specific ligands
|
|
WO1996036613A1
(en)
|
1995-05-19 |
1996-11-21 |
Nippon Soda Co., Ltd. |
Substituted benzoic acid derivatives, process for the production thereof, and herbicides
|
|
US6403599B1
(en)
|
1995-11-08 |
2002-06-11 |
Pfizer Inc |
Corticotropin releasing factor antagonists
|
|
US6956047B1
(en)
|
1995-06-06 |
2005-10-18 |
Pfizer Inc. |
Corticotropin releasing factor antagonists
|
|
KR0169813B1
(ko)
|
1995-07-12 |
1999-01-15 |
김종인 |
4-아미노-3-아실나프티리딘 유도체
|
|
DE59606057D1
(de)
|
1995-08-31 |
2000-11-30 |
Lonza Ag |
Verfahren zur herstellung von dihydroxypyrimidin-derivaten
|
|
WO1997015549A1
(en)
|
1995-10-26 |
1997-05-01 |
Tokyo Tanabe Company Limited |
PHENYLETHANOLAMINE COMPOUNDS USEFUL AS β3 AGONIST, PROCESS FOR PRODUCING THE SAME, AND INTERMEDIATES IN THE PRODUCTION OF THE SAME
|
|
US5849759A
(en)
|
1995-12-08 |
1998-12-15 |
Berlex Laboratories, Inc. |
Naphthyl-substituted benzimidazole derivatives as anti-coagulants
|
|
USH2007H1
(en)
|
1996-01-19 |
2001-12-04 |
Fmc Corporation |
Insecticidal N-heterocyclylalkyl-or N-[(polycyclyl)alkyl]-N′substituted piperazines
|
|
DE19602095A1
(de)
|
1996-01-22 |
1997-07-24 |
Bayer Ag |
Halogenpyrimidine
|
|
WO1997028137A1
(en)
|
1996-02-02 |
1997-08-07 |
Merck & Co., Inc. |
Heterocyclic derivatives as antidiabetic and antiobesity agents
|
|
AU713673B2
(en)
|
1996-02-07 |
1999-12-09 |
Neurocrine Biosciences Inc. |
Pyrazolopyrimidines as crf receptor antagonists
|
|
US5948786A
(en)
|
1996-04-12 |
1999-09-07 |
Sumitomo Pharmaceuticals Company, Limited |
Piperidinylpyrimidine derivatives
|
|
DE122010000020I1
(de)
|
1996-04-25 |
2010-07-08 |
Prosidion Ltd |
Verfahren zur Senkung des Blutglukosespiegels in Säugern
|
|
DE19624659A1
(de)
|
1996-06-20 |
1998-01-08 |
Klinge Co Chem Pharm Fab |
Neue Pyridylalken- und Pyridylalkinsäureamide
|
|
AU3176297A
(en)
|
1996-06-25 |
1998-01-14 |
Novartis Ag |
Substituted 7-amino-pyrrolo{3,2-d}pyrimidines and the use thereof
|
|
US6060478A
(en)
|
1996-07-24 |
2000-05-09 |
Dupont Pharmaceuticals |
Azolo triazines and pyrimidines
|
|
US5776967A
(en)
|
1996-07-26 |
1998-07-07 |
American Home Products Corporation |
Pyranoindole inhibitors of COX--2
|
|
AR008789A1
(es)
|
1996-07-31 |
2000-02-23 |
Bayer Corp |
Piridinas y bifenilos substituidos
|
|
US5830911A
(en)
|
1996-08-14 |
1998-11-03 |
American Home Products Corporation |
Pyranoindole and tetrahydrocarbazole inhibitors of COX-2
|
|
TW477787B
(en)
|
1996-08-27 |
2002-03-01 |
Pfizer |
Pyrido six-membered nitrogen-containing cyclic ring derivatives having corticotropin releasing factor antagonist activity and pharmaceutical composition containing same
|
|
JP3621706B2
(ja)
|
1996-08-28 |
2005-02-16 |
ファイザー・インク |
置換された６，５―ヘテロ―二環式誘導体
|
|
US6008234A
(en)
|
1996-09-12 |
1999-12-28 |
Berlex Laboratories, Inc. |
Benzamidine derivatives substituted by cyclic amino acid and cyclic hydroxy acid derivatives and their use as anti-coagulants
|
|
EP0929547B1
(en)
|
1996-09-12 |
2002-11-27 |
Schering Aktiengesellschaft |
Benzamidine derivatives substituted by cyclic amino acid or cycl ic hydroxy acid derivatives and their use as anti-coagulants
|
|
GB9718972D0
(en)
|
1996-09-25 |
1997-11-12 |
Zeneca Ltd |
Chemical compounds
|
|
TW492957B
(en)
|
1996-11-07 |
2002-07-01 |
Novartis Ag |
N-substituted 2-cyanopyrrolidnes
|
|
DZ2376A1
(fr)
|
1996-12-19 |
2002-12-28 |
Smithkline Beecham Plc |
Dérivés de sulfonamides nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant.
|
|
IL123232A0
(en)
|
1997-02-11 |
1999-11-30 |
Lilly Co Eli |
Medicament for inhibiting glucose metabolism deterioration
|
|
AU6279598A
(en)
|
1997-02-18 |
1998-09-08 |
Neurocrine Biosciences, Inc. |
Biazacyclic CRF antagonists
|
|
NZ335823A
(en)
|
1997-04-22 |
2001-06-29 |
Neurocrine Biosciences Inc |
Thiophenopyridines, preparation as CRF receptor antagonists
|
|
DE69818248T2
(de)
|
1997-04-22 |
2004-06-17 |
Janssen Pharmaceutica N.V. |
Chinolin- und chinazolin-derivate als crf antagonisten
|
|
JPH11193277A
(ja)
|
1997-05-14 |
1999-07-21 |
Nippon Soda Co Ltd |
ピリミジン誘導体、その製法および有害生物防除剤
|
|
DE19737723A1
(de)
|
1997-08-14 |
1999-02-18 |
Bayer Ag |
Methoximinomethyloxadiazine
|
|
BR9811939A
(pt)
|
1997-08-14 |
2000-09-05 |
Bayer Ag |
Metoximinometiloxadiazinas como pesticidas
|
|
NL1010018C2
(nl)
|
1997-09-09 |
1999-03-10 |
Duphar Int Res |
Chinoline en chinazoline derivaten met corticotropine releasing factor (CRF) antagonistische werking.
|
|
CN1062110C
(zh)
|
1997-09-19 |
2001-02-21 |
山东工程学院 |
带式钵苗喂入机构
|
|
US6861448B2
(en)
|
1998-01-14 |
2005-03-01 |
Virtual Drug Development, Inc. |
NAD synthetase inhibitors and uses thereof
|
|
US6187777B1
(en)
|
1998-02-06 |
2001-02-13 |
Amgen Inc. |
Compounds and methods which modulate feeding behavior and related diseases
|
|
AU3378799A
(en)
|
1998-04-02 |
1999-10-25 |
Neurogen Corporation |
Aminoalkyl substituted pyrrolo(2,3-b)pyridine and pyrrolo(2,3-d)pyrimidine derivatives: modulators of crf1 receptors
|
|
JP2000038350A
(ja)
|
1998-05-18 |
2000-02-08 |
Yoshitomi Pharmaceut Ind Ltd |
糖尿病治療薬
|
|
EP1105394A1
(en)
|
1998-08-21 |
2001-06-13 |
Du Pont Pharmaceuticals Company |
ISOXAZOLO 4,5-d]PYRIMIDINES AS CRF ANTAGONISTS
|
|
SK287270B6
(sk)
|
1998-11-10 |
2010-05-07 |
Janssen Pharmaceutica N. V. |
Derivát pyrimidínu
|
|
US6262088B1
(en)
|
1998-11-19 |
2001-07-17 |
Berlex Laboratories, Inc. |
Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants
|
|
DK1584683T3
(da)
|
1998-11-20 |
2007-10-29 |
Arena Pharm Inc |
Human G-protein-koblet orphan receptor RUP3
|
|
CO5150173A1
(es)
|
1998-12-10 |
2002-04-29 |
Novartis Ag |
Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv
|
|
EP1140831A1
(en)
|
1998-12-17 |
2001-10-10 |
American Home Products Corporation |
Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine urea derivatives having 5ht1a receptor activity
|
|
US6239126B1
(en)
|
1998-12-17 |
2001-05-29 |
American Home Products Corporation |
Arylpiperidine and aryl-1,2,5,6-tetra-hydropyridine urea derivatives
|
|
HUP0104987A3
(en)
|
1998-12-18 |
2002-09-30 |
Axys Pharmaceuticals Inc South |
Benzimidazole or indole derivatives protease inhibitors, and pharmaceutical compositions containing them
|
|
CZ27399A3
(cs)
|
1999-01-26 |
2000-08-16 |
Ústav Experimentální Botaniky Av Čr |
Substituované dusíkaté heterocyklické deriváty, způsob jejich přípravy, tyto deriváty pro použití jako léčiva, farmaceutická kompozice a kombinovaný farmaceutický přípravek tyto deriváty obsahující a použití těchto derivátů pro výrobu léčiv
|
|
US6267985B1
(en)
|
1999-06-30 |
2001-07-31 |
Lipocine Inc. |
Clear oil-containing pharmaceutical compositions
|
|
AU761453B2
(en)
|
1999-03-17 |
2003-06-05 |
Astrazeneca Ab |
Amide derivatives
|
|
EP1040831A3
(en)
|
1999-04-02 |
2003-05-02 |
Pfizer Products Inc. |
Use of corticotropin releasing factor (CRF) antagonists to prevent sudden death
|
|
YU72201A
(sh)
|
1999-04-28 |
2005-07-19 |
Aventis Pharma Deutschland Gmbh. |
Derivati di-aril kiseline kao ppar receptorski ligandi
|
|
EP1074549B1
(en)
|
1999-08-06 |
2003-11-19 |
F. Hoffmann-La Roche Ag |
Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors
|
|
JP2003509428A
(ja)
|
1999-09-17 |
2003-03-11 |
アボツト・ゲー・エム・ベー・ハー・ウント・コンパニー・カーゲー |
治療薬としてのピラゾロピリミジン
|
|
US6921763B2
(en)
|
1999-09-17 |
2005-07-26 |
Abbott Laboratories |
Pyrazolopyrimidines as therapeutic agents
|
|
US6414002B1
(en)
|
1999-09-22 |
2002-07-02 |
Bristol-Myers Squibb Company |
Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
|
|
JP2001089452A
(ja)
|
1999-09-22 |
2001-04-03 |
Sankyo Co Ltd |
ピリミジン誘導体
|
|
TR200200763T2
(tr)
|
1999-09-24 |
2003-09-22 |
Janssen Pharmaceutica N.V. |
Antiviral bileşimler
|
|
ES2277855T3
(es)
|
1999-09-30 |
2007-08-01 |
Neurogen Corporation |
Pirazolo-(1,5-a)-1,5-pirimidinas y pirazolo-(1,5-a)-1,3,5-triazinas amino sustituidas.
|
|
PL354784A1
(en)
|
1999-09-30 |
2004-02-23 |
Neurogen Corporation |
Certain alkylene diamine-substituted heterocycles
|
|
CA2379585C
(en)
|
1999-09-30 |
2006-06-20 |
James W. Darrow |
Certain alkylene diamine-substituted pyrazolo[1,5,-a]-1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines
|
|
DE19947154A1
(de)
|
1999-10-01 |
2001-10-04 |
Bayer Ag |
Substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung
|
|
US6887870B1
(en)
|
1999-10-12 |
2005-05-03 |
Bristol-Myers Squibb Company |
Heterocyclic sodium/proton exchange inhibitors and method
|
|
CO5271670A1
(es)
|
1999-10-29 |
2003-04-30 |
Pfizer Prod Inc |
Antagonistas del factor de liberacion de corticitropina y composiciones relacionadas
|
|
GR990100388A
(el)
|
1999-11-09 |
2001-07-31 |
|
Φαρμακευτικος συνδυασμος αποτελουμενος απο χωριστες δοσολογικες μορφες σε συσκευασια συμμορφωσης (compliance package) ενος αναστολεα της αναγωγασης του υδροξυ-μεθυλο-γλουταρυλο συνενζυμου α (στατινης, statin) και ενος παραγωγου του φιμπρικου οξεος....
|
|
JP2003518128A
(ja)
|
1999-12-22 |
2003-06-03 |
メルク フロスト カナダ アンド カンパニー |
タンパク質チロシンホスファターゼ１ｂ（ｐｔｐ−１ｂ）のインヒビターとなる芳香族ホスホネート
|
|
DE19962936A1
(de)
|
1999-12-24 |
2001-06-28 |
Bayer Ag |
Neue beta-Aminosäureverbindungen als Integrinantagonisten
|
|
IL150337A0
(en)
|
1999-12-30 |
2002-12-01 |
Lundbeck & Co As H |
Phenylpiperazinyl derivatives
|
|
HUP0204272A3
(en)
|
2000-01-18 |
2005-03-29 |
Pfizer Prod Inc |
Corticotropin releasing factor antagonists, pharmaceutical compositions containing them and their use
|
|
CA2399136A1
(en)
|
2000-02-09 |
2001-08-16 |
Hideo Kato |
1h-imidazopyridine derivatives
|
|
JP2003523418A
(ja)
|
2000-02-15 |
2003-08-05 |
フオスター・ミラー・インコーポレイテツド |
揮発性有機成分を含まない放射硬化性樹脂組成物
|
|
JP2003523336A
(ja)
|
2000-02-18 |
2003-08-05 |
メルク エンド カムパニー インコーポレーテッド |
糖尿病及び脂質障害のためのアリールオキシ酢酸
|
|
US6569879B2
(en)
|
2000-02-18 |
2003-05-27 |
Merck & Co., Inc. |
Aryloxyacetic acids for diabetes and lipid disorders
|
|
WO2001062233A2
(en)
|
2000-02-25 |
2001-08-30 |
F. Hoffmann La Roche Ag |
Adenosine receptor modulators
|
|
CN1440283A
(zh)
|
2000-04-12 |
2003-09-03 |
诺瓦提斯公司 |
有机化合物的联合形式
|
|
AU782948B2
(en)
|
2000-05-08 |
2005-09-15 |
Janssen Pharmaceutica N.V. |
Prodrugs of HIV replication inhibiting pyrimidines
|
|
DE10024319A1
(de)
|
2000-05-17 |
2001-11-22 |
Merck Patent Gmbh |
Bisacylguanidine
|
|
EP1287133B1
(en)
|
2000-05-18 |
2006-12-13 |
Bayer HealthCare AG |
Regulation of human dopamine-like g protein-coupled receptor
|
|
US6440960B1
(en)
|
2000-05-18 |
2002-08-27 |
Neurocrine Biosciences, Inc. |
CRF receptor antagonists and methods relating thereto
|
|
EP1289964B1
(en)
|
2000-05-25 |
2004-10-20 |
F. Hoffmann-La Roche Ag |
Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
|
|
US6620821B2
(en)
|
2000-06-15 |
2003-09-16 |
Bristol-Myers Squibb Company |
HMG-CoA reductase inhibitors and method
|
|
JP2004501191A
(ja)
|
2000-06-28 |
2004-01-15 |
テバ ファーマシューティカル インダストリーズ リミティド |
カルベジロール
|
|
EP1294704A1
(en)
|
2000-06-29 |
2003-03-26 |
Abbott Laboratories |
Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
|
|
AR028782A1
(es)
|
2000-07-05 |
2003-05-21 |
Taisho Pharmaceutical Co Ltd |
Derivados heterociclicos tetrahidropiridino o piperidino
|
|
US6444685B1
(en)
|
2000-07-17 |
2002-09-03 |
Wyeth |
N-(4-sulfonylaryl)Cyclylamine 2-hydroxyethylamines as beta-3 adrenergic receptor agonists
|
|
CA2415899A1
(en)
|
2000-07-18 |
2003-01-13 |
Chikashi Saitoh |
Medicine comprising dicyanopyridine derivative
|
|
AU7705601A
(en)
|
2000-07-25 |
2002-02-05 |
Merck & Co Inc |
N-substituted indoles useful in the treatment of diabetes
|
|
US6410583B1
(en)
|
2000-07-25 |
2002-06-25 |
Merck Frosst Canada & Co. |
Cyclopentanoindoles, compositions containing such compounds and methods of treatment
|
|
AU2001284417A1
(en)
|
2000-09-05 |
2002-03-22 |
Taisho Pharmaceutical Co. Ltd. |
Hair growth stimulants
|
|
ATE367802T1
(de)
|
2000-09-20 |
2007-08-15 |
Jagotec Ag |
Verfahren zur sprühtrocknung von zusammensetzungen enthaltend fenofibrat
|
|
US7276249B2
(en)
|
2002-05-24 |
2007-10-02 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
|
US20030224058A1
(en)
|
2002-05-24 |
2003-12-04 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
|
PE20020507A1
(es)
|
2000-10-17 |
2002-06-25 |
Schering Corp |
Compuestos no-imidazoles como antagonistas del receptor histamina h3
|
|
AU2002223626A1
(en)
|
2000-10-20 |
2002-04-29 |
Novartis Ag |
Combinations of a thyromimetic compound and a statin
|
|
CN100525768C
(zh)
|
2000-10-23 |
2009-08-12 |
史密丝克莱恩比彻姆公司 |
新化合物
|
|
AU2002248221B2
(en)
|
2000-10-31 |
2006-08-17 |
Merck & Co., Inc. |
Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
|
|
DE60126134T2
(de)
|
2000-11-03 |
2007-10-18 |
Neurocrine Biosciences, Inc., San Diego |
CRF-Rezeptorantagonisten und Verfahren, die damit in Beziehung stehen
|
|
US20020058026A1
(en)
|
2000-11-13 |
2002-05-16 |
Milton Hammerly |
HMG CoA reductase inhibitor medications combined wih CoEnzyme Q-10
|
|
WO2002039987A2
(en)
|
2000-11-14 |
2002-05-23 |
Neurosearch A/S |
Use of malaria parasite anion channel blockers for treating malaria
|
|
UA77165C2
(en)
|
2000-11-17 |
2006-11-15 |
Lilly Co Eli |
(n)-((s)-2-hydroxy-3-methyl-butyryl)-1-(l-alaninyl)-(s)-1-amino-3-methyl-4,5,6,7-tetrahydro-2h-3-benzazepin-2-one dihydrate, processes for manufacturing and pharmaceutical composition
|
|
EP1340749A4
(en)
|
2000-11-17 |
2007-09-05 |
Takeda Pharmaceutical |
ISOXAZOLE DERIVATIVES
|
|
CA2448729A1
(en)
|
2000-11-20 |
2002-05-23 |
Biovitrum Ab |
Piperazinyl and piperidyl substituted heterocyclic compounds
|
|
EP1338651B9
(en)
|
2000-12-01 |
2007-05-09 |
Astellas Pharma Inc. |
Method of screening remedy for diabetes
|
|
US20020137755A1
(en)
|
2000-12-04 |
2002-09-26 |
Bilodeau Mark T. |
Tyrosine kinase inhibitors
|
|
US20020107262A1
(en)
|
2000-12-08 |
2002-08-08 |
3M Innovative Properties Company |
Substituted imidazopyridines
|
|
US6545016B1
(en)
|
2000-12-08 |
2003-04-08 |
3M Innovative Properties Company |
Amide substituted imidazopyridines
|
|
US6525064B1
(en)
|
2000-12-08 |
2003-02-25 |
3M Innovative Properties Company |
Sulfonamido substituted imidazopyridines
|
|
US6545017B1
(en)
|
2000-12-08 |
2003-04-08 |
3M Innovative Properties Company |
Urea substituted imidazopyridines
|
|
WO2002050071A1
(en)
|
2000-12-21 |
2002-06-27 |
Bristol-Myers Squibb Company |
Thiazolyl inhibitors of tec family tyrosine kinases
|
|
DK1355644T3
(da)
|
2001-01-26 |
2006-10-23 |
Schering Corp |
Anvendelse af substituerede azetidinonforbindelser til behandling af sitosterolæmi
|
|
JP2004529100A
(ja)
|
2001-01-30 |
2004-09-24 |
ユニバーシティ オブ バージニア パテント ファウンデーション |
スフィンゴシン−１−ホスフェートレセプターのアゴニストおよびアンタゴニスト
|
|
EP1357908A4
(en)
|
2001-01-30 |
2009-07-15 |
Merck & Co Inc |
"ACYLSULFAMIDES FOR THE TREATMENT OF FATIBILITY, DIABETES AND LIPID DISORDERS"
|
|
CN100439370C
(zh)
|
2001-02-08 |
2008-12-03 |
记忆药物公司 |
作为磷酸二酯酶4抑制剂的三氟甲基嘌呤
|
|
CA2437118A1
(en)
|
2001-02-09 |
2002-08-22 |
Merck & Co., Inc. |
2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders
|
|
DE10110754A1
(de)
|
2001-03-07 |
2002-09-19 |
Bayer Ag |
Substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung
|
|
WO2002072101A1
(en)
|
2001-03-13 |
2002-09-19 |
Bristol-Myers Squibb Pharma Company |
A corticotropin releasing factor receptor ligand, its enantiomer and pharmaceutically acceptable salts
|
|
WO2002079131A1
(en)
|
2001-03-29 |
2002-10-10 |
Kansai Research Institute, Inc. |
Optically active compound and photosensitive resin composition
|
|
WO2002081454A1
(en)
|
2001-04-09 |
2002-10-17 |
Dr. Reddy's Laboratories Ltd. |
Derivatives of aryl acids, their use in medicine, process for their preparation and pharmaceutical compositions containing them
|
|
CN1293072C
(zh)
|
2001-04-20 |
2007-01-03 |
惠氏公司 |
作为5－羟色胺－6配体的杂环基氧基－、－硫代－和－氨基吲哚衍生物
|
|
ES2316613T3
(es)
|
2001-05-10 |
2009-04-16 |
Ono Pharmaceutical Co., Ltd. |
Derivados de acido crboxilico y composiciones farmaceuticas que contienen los mismos como ingrediente activo.
|
|
DK1397351T3
(da)
|
2001-06-01 |
2010-01-18 |
Hoffmann La Roche |
Pyrimidin-, triazin- og pyrazinderivater som glutamatreceptorer
|
|
CA2450934A1
(en)
|
2001-06-19 |
2002-12-27 |
Marco Dodier |
Pyrimidine inhibitors of phosphodiesterase (pde) 7
|
|
US6825198B2
(en)
|
2001-06-21 |
2004-11-30 |
Pfizer Inc |
5-HT receptor ligands and uses thereof
|
|
AU2002316421B2
(en)
|
2001-06-26 |
2008-05-15 |
Bristol-Myers Squibb Company |
N-heterocyclic inhibitors of TNF-ALPHA expression
|
|
UA74912C2
(en)
|
2001-07-06 |
2006-02-15 |
Merck & Co Inc |
Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes
|
|
GB0117899D0
(en)
|
2001-07-23 |
2001-09-12 |
Astrazeneca Ab |
Chemical compounds
|
|
WO2003026661A1
(fr)
|
2001-09-14 |
2003-04-03 |
Yamanouchi Pharmaceutical Co., Ltd. |
Accelerateur de secretion de l'insuline et nouveau derive de pyrimidine
|
|
CA2461212C
(en)
|
2001-09-27 |
2010-08-17 |
Kyorin Pharmaceutical Co., Ltd. |
Diaryl sulfide derivatives, salts thereof and immunosuppressive agents using the same
|
|
EP1438048A1
(en)
|
2001-10-18 |
2004-07-21 |
Boehringer Ingelheim Pharmaceuticals Inc. |
1,4-disubstituted benzo-fused urea compounds as cytokine inhibitors
|
|
GB0229931D0
(en)
|
2002-12-21 |
2003-01-29 |
Astrazeneca Ab |
Therapeutic agents
|
|
SE0104334D0
(sv)
|
2001-12-19 |
2001-12-19 |
Astrazeneca Ab |
Therapeutic agents
|
|
WO2003059378A2
(en)
|
2001-12-29 |
2003-07-24 |
Novo Nordisk A/S |
Combined use of a glp-1 compound and another drug for treating dyslipidemia
|
|
WO2003057689A1
(en)
|
2002-01-02 |
2003-07-17 |
Fujisawa Pharmaceutical Co., Ltd. |
Aminopyrimidine compounds, processes for their preparation and pharmaceutical compositions containing them
|
|
US20070225351A1
(en)
|
2002-01-11 |
2007-09-27 |
Lippa Arnold S |
Methods and compositions for controlling body weight and appetite
|
|
JP4430941B2
(ja)
|
2002-01-18 |
2010-03-10 |
メルク エンド カムパニー インコーポレーテッド |
Ｅｄｇ受容体作動薬
|
|
WO2003061567A2
(en)
|
2002-01-18 |
2003-07-31 |
Merck & Co., Inc. |
Selective s1p1/edg1 receptor agonists
|
|
JP2005516967A
(ja)
|
2002-01-18 |
2005-06-09 |
ザ ジェネティクス カンパニー インコーポレーティッド |
β−セクレターゼインヒビター
|
|
GB0201850D0
(en)
|
2002-01-26 |
2002-03-13 |
Astrazeneca Ab |
Therapeutic treatment
|
|
WO2003074008A2
(en)
|
2002-03-01 |
2003-09-12 |
Merck & Co., Inc. |
Aminoalkylphosphonates and related compounds as edg receptor agonists
|
|
JP2005531506A
(ja)
|
2002-03-01 |
2005-10-20 |
メルク エンド カムパニー インコーポレーテッド |
Ｅｄｇ受容体作動薬としてのアミノアルキルホスホネートおよび関連化合物
|
|
ATE507210T1
(de)
|
2002-03-07 |
2011-05-15 |
X Ceptor Therapeutics Inc |
Chinazolinon modulatoren von nukleinrezeptoren
|
|
US7731985B2
(en)
|
2002-03-15 |
2010-06-08 |
Ciba Specialty Chemicals Corporation |
4-aminopyrimidines and their use for the antimicrobial treatment of surfaces
|
|
TW200810743A
(en)
|
2002-03-22 |
2008-03-01 |
Novartis Ag |
Combination of organic compounds
|
|
AU2003225027A1
(en)
|
2002-04-16 |
2003-11-03 |
Merck And Co., Inc. |
Combination therapy using a ppar alpha/gamma agonist
|
|
AU2003222786A1
(en)
|
2002-04-18 |
2003-10-27 |
Ucb, S.A. |
Chemical compounds with dual activity, processes for their preparation and pharmaceutical compositions
|
|
DE10219435A1
(de)
|
2002-05-02 |
2003-11-13 |
Bayer Cropscience Ag |
Substituierte Pyrazolo-pyrimidin-4-one
|
|
WO2003094845A2
(en)
|
2002-05-08 |
2003-11-20 |
Bristol-Myers Squibb Company |
Pyridine-based thyroid receptor ligands
|
|
US7057046B2
(en)
|
2002-05-20 |
2006-06-06 |
Bristol-Myers Squibb Company |
Lactam glycogen phosphorylase inhibitors and method of use
|
|
CA2488617A1
(en)
|
2002-06-10 |
2003-12-18 |
Eugene R. Cooper |
Nanoparticulate sterol formulations and sterol combinations
|
|
AR040241A1
(es)
|
2002-06-10 |
2005-03-23 |
Merck & Co Inc |
Inhibidores de la 11-beta-hidroxiesteroide deshidrogrenasa 1 para el tratamiento de la diabetes obesidad y dislipidemia
|
|
JP4533134B2
(ja)
|
2002-06-10 |
2010-09-01 |
エラン ファーマ インターナショナル，リミティド |
ナノ粒子ポリコサノール製剤および新規なポリコサノールの組合せ
|
|
WO2003103640A1
(en)
|
2002-06-10 |
2003-12-18 |
Elan Pharma International, Ltd |
Nanoparticulate formulations comprising hmg coa reductase inhibitor derivatives (“statins”), novel combinations thereof as well as manufacturing of these pharmaceutical compositions
|
|
WO2003105763A2
(en)
|
2002-06-14 |
2003-12-24 |
Amylin Pharmaceuticals, Inc. |
Prevention and/or treatment of inflammatory bowel disease using pyy or agonists thereof
|
|
JP2005533058A
(ja)
|
2002-06-17 |
2005-11-04 |
メルク エンド カムパニー インコーポレーテッド |
Ｅｄｇ受容体アゴニストとしての１−（（５−アリール−１，２，４−オキサジアゾール−３−イル）ベンジル）アゼチジン−３−カルボキシラートおよび１−（（５−アリール−１，２，４−オキサジアゾール−３−イル）ベンジル）ピロリジン−３−カルボキシラート
|
|
DE10226943A1
(de)
|
2002-06-17 |
2004-01-08 |
Bayer Ag |
Phenylaminopyrimidine und ihre Verwendung
|
|
GB0214254D0
(en)
|
2002-06-20 |
2002-07-31 |
Glaxo Group Ltd |
Chemical compounds
|
|
SE0201980D0
(sv)
|
2002-06-24 |
2002-06-24 |
Astrazeneca Ab |
Novel compounds
|
|
SE0201976D0
(sv)
|
2002-06-24 |
2002-06-24 |
Astrazeneca Ab |
Novel compounds
|
|
US20060014717A1
(en)
|
2002-06-28 |
2006-01-19 |
Glykos Finland Oy |
Therapeutic compositions for use in prophylaxis or treatment of diarrheas
|
|
US20040053842A1
(en)
|
2002-07-02 |
2004-03-18 |
Pfizer Inc. |
Methods of treatment with CETP inhibitors and antihypertensive agents
|
|
US7071210B2
(en)
|
2002-07-02 |
2006-07-04 |
Pfizer Inc. |
CETP inhibitors in combination with antihypertensive agents and uses thereof
|
|
AU2003252478A1
(en)
|
2002-07-10 |
2004-02-02 |
Ono Pharmaceutical Co., Ltd. |
Ccr4 antagonist and medicinal use thereof
|
|
AU2003261204A1
(en)
|
2002-07-23 |
2004-02-09 |
Smithkline Beecham Corporation |
Pyrazolopyrimidines as kinase inhibitors
|
|
AU2003254053A1
(en)
|
2002-07-23 |
2004-02-09 |
Smithkline Beecham Corporation |
Pyrazolopyrimidines as protein kinase inhibitors
|
|
JP2006514918A
(ja)
|
2002-07-23 |
2006-05-18 |
スミスクライン ビーチャム コーポレーション |
キナーゼインヒビターとしてのピラゾロピリミジン
|
|
US20060105445A1
(en)
|
2002-07-29 |
2006-05-18 |
Klaus Godl |
Medium and method for enriching, purifying or depleting atp binding proteins from a pool of proteins
|
|
EP1539137B1
(en)
|
2002-07-30 |
2010-05-26 |
Merck Sharp & Dohme Corp. |
Ppar alpha selective compounds for the treatment of dyslipidemia and other lipid disorders
|
|
US7241790B2
(en)
|
2002-07-30 |
2007-07-10 |
University Of Virginia Patent Foundation |
Compounds active in spinigosine 1-phosphate signaling
|
|
JP4475406B2
(ja)
|
2002-07-30 |
2010-06-09 |
メルク・シャープ・エンド・ドーム・コーポレイション |
異常脂血症および他の脂質障害の治療用のＰＰＡＲα選択的化合物
|
|
JP2004067575A
(ja)
|
2002-08-06 |
2004-03-04 |
Yaizu Suisankagaku Industry Co Ltd |
糖尿病治療薬効果促進剤
|
|
AR041191A1
(es)
|
2002-08-08 |
2005-05-04 |
Amgen Inc |
Ligandos del receptor vanilloide y su uso en tratamientos
|
|
DE10237722A1
(de)
|
2002-08-17 |
2004-08-19 |
Aventis Pharma Deutschland Gmbh |
Indol- oder Benzimidazolderivate zur Modulation der IKappaB-Kinase
|
|
US20060167045A1
(en)
|
2002-08-21 |
2006-07-27 |
Joanne Waldstreicher |
Combination therapy using a dual ppar alpha/gamma agonist and an angiotensin II type I receptor antagonist
|
|
EP1546142A4
(en)
|
2002-08-29 |
2007-10-17 |
Merck & Co Inc |
INDOLES HAVING ANTIDIABETIC EFFECT
|
|
CN100457730C
(zh)
|
2002-08-29 |
2009-02-04 |
默克公司 |
具有抗糖尿病活性的吲哚化合物
|
|
EP1538217A4
(en)
|
2002-09-11 |
2006-09-27 |
Astellas Pharma Inc |
SCREENING METHOD FOR INSULATION STOP ENHANCER
|
|
JP2006510597A
(ja)
|
2002-09-27 |
2006-03-30 |
メルク エンド カムパニー インコーポレーテッド |
置換ピリミジン類
|
|
US7067658B2
(en)
|
2002-09-30 |
2006-06-27 |
Bristol-Myers Squibb Company |
Pyridino and pyrimidino pyrazinones
|
|
AU2003282679A1
(en)
|
2002-10-04 |
2004-05-04 |
Arena Pharmaceuticals, Inc. |
Hydroxypyrazoles for use against metabolic-related disorders
|
|
AU2003284111A1
(en)
|
2002-10-09 |
2004-05-04 |
Genaissance Pharmaceuticals, Inc. |
Itgb3 gene haplotypes and atorvastatin dose effects on hdl cholesterol
|
|
EP1551842A1
(en)
|
2002-10-15 |
2005-07-13 |
Smithkline Beecham Corporation |
Pyradazine compounds as gsk-3 inhibitors
|
|
US7129239B2
(en)
|
2002-10-28 |
2006-10-31 |
Pfizer Inc. |
Purine compounds and uses thereof
|
|
CA2503715A1
(en)
|
2002-10-30 |
2004-05-21 |
Merck & Co., Inc. |
Kinase inhibitors
|
|
CA2505322A1
(en)
|
2002-11-08 |
2004-05-21 |
Takeda Pharmaceutical Company Limited |
Receptor function regulator
|
|
US7098235B2
(en)
|
2002-11-14 |
2006-08-29 |
Bristol-Myers Squibb Co. |
Triglyceride and triglyceride-like prodrugs of glycogen phosphorylase inhibiting compounds
|
|
US20040110241A1
(en)
|
2002-12-06 |
2004-06-10 |
Segal Mark S. |
Materials and methods for monitoring vascular endothelial function
|
|
WO2004058727A1
(en)
|
2002-12-20 |
2004-07-15 |
Bayer Pharmaceuticals Corporation |
Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity
|
|
JO2397B1
(en)
|
2002-12-20 |
2007-06-17 |
ميرك شارب اند دوم كوربوريشن |
Terazol derivatives as beta-hydroxy steroid dihydrogenase-1 inhibitors
|
|
EP1578715B1
(en)
|
2002-12-20 |
2011-03-02 |
Bayer Pharmaceuticals Corporation |
Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
|
|
DE60335827D1
(de)
|
2002-12-20 |
2011-03-03 |
Merck Sharp & Dohme |
1-(amino)indane als edg-rezeptoragonisten
|
|
GB0230021D0
(en)
|
2002-12-23 |
2003-01-29 |
Syngenta Ltd |
Fungicides
|
|
GB0230020D0
(en)
|
2002-12-23 |
2003-01-29 |
Syngenta Ltd |
Fungicides
|
|
MXPA05007485A
(es)
|
2003-01-14 |
2006-01-30 |
Arena Pharm Inc |
Derivados de arilo y heteroarilo 1,2,3-trisubstituidos como moduladores del metabolismo y la profilaxis y tratamiento de trastornos relacionados con ello tales como diabetes e hiperglicemia.
|
|
WO2004062665A1
(en)
|
2003-01-16 |
2004-07-29 |
Sb Pharmco Puerto Rico Inc |
Heteroaryl- substituted pyrrolo` 2, 3- b! pyridine derivatives as crf receptor antagonists
|
|
AU2004207444B2
(en)
|
2003-01-17 |
2008-07-31 |
Merck & Co., Inc. |
N-cyclohexylaminocarbonyl benzenesulfonamide derivatives
|
|
PL378134A1
(pl)
|
2003-02-11 |
2006-03-06 |
Irm Llc |
Nowe pochodne bicykliczne i kompozycje farmaceutyczne zawierające pochodne bicykliczne
|
|
TW200418829A
(en)
|
2003-02-14 |
2004-10-01 |
Avanir Pharmaceutics |
Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
|
|
BRPI0407658A
(pt)
|
2003-02-18 |
2006-02-21 |
Kyorin Seiyaku Kk |
derivados de ácido aminofosfÈnico, seus sais e hidratos que atuam como moduladores de receptor de s1p e agente farmacêutico
|
|
WO2004076413A2
(en)
|
2003-02-24 |
2004-09-10 |
Arena Pharmaceuticals, Inc. |
Phenyl- and pyridylpiperidine-derivatives as modulators of glucose metabolism
|
|
JP2004269469A
(ja)
|
2003-03-12 |
2004-09-30 |
Yamanouchi Pharmaceut Co Ltd |
ピリミジン誘導体又はその塩
|
|
JP2004269468A
(ja)
|
2003-03-12 |
2004-09-30 |
Yamanouchi Pharmaceut Co Ltd |
ピリミジン誘導体又はその塩
|
|
JP2006521344A
(ja)
|
2003-03-28 |
2006-09-21 |
ファイザー・プロダクツ・インク |
アテローム性動脈硬化症および肥満の治療のためのｃｅｔｐ阻害剤としての１，２，４−置換１，２，３，４−テトラヒドロ−および１，２−ジヒドロ−キノリンおよび１，２，３，４−テトラヒドロ−キノキサリン誘導体
|
|
MXPA05011597A
(es)
|
2003-04-30 |
2005-12-15 |
Novartis Ag |
Derivados de aminopropanol como moduladores del receptor 1-fosfato de esfingosina.
|
|
CN1777575B
(zh)
|
2003-04-30 |
2010-05-12 |
诺瓦提斯公司 |
作为1-磷酸-鞘氨醇受体调节剂的氨基-丙醇衍生物
|
|
US7329680B2
(en)
|
2003-04-30 |
2008-02-12 |
The Institute For Pharmaceutical Discovery, Llc |
Heterocycle substituted carboxylic acids
|
|
TWI494102B
(zh)
|
2003-05-02 |
2015-08-01 |
Japan Tobacco Inc |
包含ｓ-〔２（〔〔１-（２-乙基丁基）環己基〕羰基〕胺基）苯基〕２-甲基丙烷硫酯及ｈｍｇ輔酶ａ還原酶抑制劑之組合
|
|
ES2351624T3
(es)
|
2003-05-06 |
2011-02-08 |
Ústav Experimentálni Botaniky Av Cr, V.V.I. (Institute Of Experimental Botany Academy Of Sciences Of The Czech Republic, Pro) |
Pirazolo[4,3-d]pirimidinas, procedimiento para su preparación y uso.
|
|
SE0301368D0
(sv)
|
2003-05-09 |
2003-05-09 |
Astrazeneca Ab |
Chemical compounds
|
|
US7083933B1
(en)
|
2003-05-09 |
2006-08-01 |
Prosidion Limited |
Methods for identification of modulators of OSGPR116 activity
|
|
AU2004240586A1
(en)
|
2003-05-15 |
2004-12-02 |
Merck & Co., Inc. |
3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles as S1P receptor agonists
|
|
WO2004104205A2
(en)
|
2003-05-16 |
2004-12-02 |
Merck & Co., Inc. |
Enzymatic preparation of chiral indole esters
|
|
CL2004001120A1
(es)
|
2003-05-19 |
2005-04-15 |
Irm Llc |
Compuestos derivados de amina sustituidas con heterociclos, inmunosupresores; composicion farmaceutica; y uso para tratar enfermedades mediadas por interacciones de linfocito, tales como enfermedades autoinmunes, inflamatorias, infecciosas, cancer.
|
|
MXPA05012459A
(es)
|
2003-05-19 |
2006-02-22 |
Irm Llc |
Compuestos y composiciones inmunosupresoras.
|
|
EP1644367B1
(en)
|
2003-05-19 |
2015-10-14 |
Novartis AG |
Immunosuppressant compounds and compositions
|
|
MY150088A
(en)
|
2003-05-19 |
2013-11-29 |
Irm Llc |
Immunosuppressant compounds and compositions
|
|
US6987118B2
(en)
|
2003-05-21 |
2006-01-17 |
Pfizer Inc. |
Tetrahydroisoquinoline derivatives as PPAR-alpha activators
|
|
EP1635773A2
(en)
|
2003-06-06 |
2006-03-22 |
Merck & Co., Inc. (a New Jersey corp.) |
Combination therapy for the treatment of hypertension
|
|
AU2003902882A0
(en)
|
2003-06-10 |
2003-06-26 |
Fujisawa Pharmaceutical Co., Ltd. |
Piperidyl derivatives
|
|
GB0313612D0
(en)
|
2003-06-12 |
2003-07-16 |
Novartis Ag |
Organic compounds
|
|
AR045047A1
(es)
|
2003-07-11 |
2005-10-12 |
Arena Pharm Inc |
Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
|
|
RS20060018A
(sr)
|
2003-07-14 |
2007-12-31 |
Arena Pharmaceuticals Inc., |
Derivati spojenih arila i heteroarila kao modulatori metabolizma u profilaksi i lečenju sa njima povezanih stanja
|
|
JPWO2005012221A1
(ja)
|
2003-08-04 |
2006-09-14 |
小野薬品工業株式会社 |
ジフェニルエーテル化合物、その製造方法および用途
|
|
PT1660458E
(pt)
|
2003-08-15 |
2012-04-27 |
Novartis Ag |
2,4-pirimidinodiaminas úteis no tratamento de doenças neoplásicas, desordens inflamatórias e do sistema imunitário
|
|
US20050043327A1
(en)
|
2003-08-21 |
2005-02-24 |
Pfizer Inc |
Pharmaceutical composition for the prevention and treatment of addiction in a mammal
|
|
ATE449069T1
(de)
|
2003-08-28 |
2009-12-15 |
Novartis Pharma Gmbh |
Aminopropanolderivate
|
|
US7825109B2
(en)
|
2003-08-29 |
2010-11-02 |
Ono Pharmaceutical Co., Ltd. |
Compound capable of binding S1P receptor and pharmaceutical use thereof
|
|
JP2007504230A
(ja)
|
2003-09-02 |
2007-03-01 |
メルク エンド カムパニー インコーポレーテッド |
ジペプチジルペプチダーゼ−ｉｖ阻害剤のリン酸塩の新規結晶性形態
|
|
WO2005023762A1
(en)
|
2003-09-04 |
2005-03-17 |
Abbott Laboratories |
Pyrrolidine-2-carbonitrile derivatives and their use as inhibitors of dipeptidyl peptidase-iv (dpp-iv)
|
|
WO2005023771A1
(ja)
|
2003-09-05 |
2005-03-17 |
Ono Pharmaceutical Co., Ltd. |
ケモカインレセプターアンタゴニストおよびその医薬用途
|
|
TWI359147B
(en)
|
2003-09-05 |
2012-03-01 |
Vertex Pharma |
Inhibitors of serine proteases, particularly hcv n
|
|
EP1699777B1
(en)
|
2003-09-08 |
2012-12-12 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
|
EP1697342A2
(en)
|
2003-09-08 |
2006-09-06 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
|
PE20050948A1
(es)
|
2003-09-09 |
2005-12-16 |
Japan Tobacco Inc |
Compuestos de carbamoil-amina como inhibidores de la dipeptidil peptidasa iv
|
|
CN1856307A
(zh)
|
2003-09-23 |
2006-11-01 |
默克公司 |
喹啉钾通道抑制剂
|
|
EP1667524A4
(en)
|
2003-09-23 |
2009-01-14 |
Merck & Co Inc |
NEW CRYSTALLINE FORM OF A PHOSPHORIC ACID SALT OF A DIPEPTIDYLPEPTIDASE IV INHIBITOR
|
|
US20070043014A1
(en)
|
2003-10-01 |
2007-02-22 |
Merck & Co., Inc. |
3,5-Aryl, heteroaryl or cycloalkyl substituted-1,2,4-oxadiazoles as s1p receptor agonists
|
|
WO2005033099A2
(en)
|
2003-10-03 |
2005-04-14 |
Glenmark Pharmaceuticals Ltd. |
Novel dipeptidyl peptidase iv inhibitors; processes for their preparation and compositions thereof
|
|
WO2005037215A2
(en)
|
2003-10-14 |
2005-04-28 |
Massachusetts Institute Of Technology |
Compositions and methods for enhancing cognitive function and synaptic plasticity
|
|
GB0324236D0
(en)
|
2003-10-16 |
2003-11-19 |
Astrazeneca Ab |
Chemical compounds
|
|
TW200523252A
(en)
|
2003-10-31 |
2005-07-16 |
Takeda Pharmaceutical |
Pyridine compounds
|
|
US7638637B2
(en)
|
2003-11-03 |
2009-12-29 |
University Of Virginia Patent Foundation |
Orally available sphingosine 1-phosphate receptor agonists and antagonists
|
|
AU2004289304A1
(en)
|
2003-11-10 |
2005-05-26 |
Synta Pharmaceuticals, Corp. |
Pyridine compounds
|
|
WO2005044780A1
(ja)
|
2003-11-10 |
2005-05-19 |
Kyorin Pharmaceutical Co., Ltd. |
アミノカルボン酸誘導体とその付加塩及びｓ１ｐ受容体調節剤
|
|
SG134333A1
(en)
|
2003-11-12 |
2007-08-29 |
Phenomix Corp |
Heterocyclic boronic acid compounds
|
|
MY141220A
(en)
|
2003-11-17 |
2010-03-31 |
Astrazeneca Ab |
Pyrazole derivatives as inhibitors of receptor tyrosine kinases
|
|
WO2005058315A1
(en)
|
2003-12-12 |
2005-06-30 |
Ribapharm, Inc. |
Novel heterocyclic compounds as ikk2 inhibitors with anti-hbv activity
|
|
WO2005058849A1
(en)
|
2003-12-15 |
2005-06-30 |
Glenmark Pharmaceuticals Ltd. |
New dipeptidyl peptidase in inhibitors; process for their preparation and compositions containing them
|
|
EP1697333A4
(en)
|
2003-12-17 |
2009-07-08 |
Merck & Co Inc |
(3,4-DISUBSTITUTED) PROPANE ACID BOXYLATES AS AGONISTS OF THE S1P (EDG) RECEPTOR
|
|
ATE528276T1
(de)
|
2003-12-19 |
2011-10-15 |
Ono Pharmaceutical Co |
Lysophosphatidylsäurerezeptor-antagonistische verbindungen und ihre anwendungen
|
|
GB0329498D0
(en)
|
2003-12-19 |
2004-01-28 |
Novartis Ag |
Organic compounds
|
|
DE10360835A1
(de)
|
2003-12-23 |
2005-07-21 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Bicyclische Imidazolverbindungen, deren Herstellung und deren Verwendung als Arzneimittel
|
|
JP4958560B2
(ja)
|
2003-12-24 |
2012-06-20 |
プロシディオン・リミテッド |
Ｇｐｃｒ受容体作動薬としてのヘテロ環誘導体
|
|
US20080227786A1
(en)
|
2004-01-16 |
2008-09-18 |
Ferlita Russell R |
Novel Crystalline Salts of a Dipeptidyl Peptidase-IV Inhibitor
|
|
GB0401332D0
(en)
|
2004-01-21 |
2004-02-25 |
Novartis Ag |
Organic compounds
|
|
WO2005075426A1
(en)
|
2004-02-03 |
2005-08-18 |
Glenmark Pharmaceuticals Ltd. |
Novel dipeptidyl peptidase iv inhibitors; processes for their preparation and compositions thereof
|
|
AU2005212438A1
(en)
|
2004-02-11 |
2005-08-25 |
Amgen Inc. |
Vanilloid receptor ligands and their use in treatments
|
|
TW200530236A
(en)
|
2004-02-23 |
2005-09-16 |
Chugai Pharmaceutical Co Ltd |
Heteroaryl phenylurea
|
|
NZ549162A
(en)
|
2004-02-24 |
2009-12-24 |
Sankyo Co |
Amino-pyrrol alcohol compounds
|
|
TW200538433A
(en)
|
2004-02-24 |
2005-12-01 |
Irm Llc |
Immunosuppressant compounds and compositiions
|
|
US7718704B2
(en)
|
2004-02-24 |
2010-05-18 |
Irm Llc |
Immunosuppressant compounds and compositions
|
|
CN1934094A
(zh)
|
2004-03-05 |
2007-03-21 |
万有制药株式会社 |
二芳基取代杂环5元环衍生物
|
|
GB0405289D0
(en)
|
2004-03-09 |
2004-04-21 |
Novartis Ag |
Organic compounds
|
|
GB0405933D0
(en)
|
2004-03-16 |
2004-04-21 |
Glaxo Group Ltd |
Compounds
|
|
JP5239071B2
(ja)
|
2004-04-02 |
2013-07-17 |
メルク・シャープ・アンド・ドーム・コーポレーション |
シクロアルカノインドール誘導体の調製のために有用な非対称水素化方法
|
|
EP1764367A1
(en)
|
2004-04-12 |
2007-03-21 |
Sankyo Company, Limited |
Thienopyridine derivatives
|
|
WO2005117909A2
(en)
|
2004-04-23 |
2005-12-15 |
Exelixis, Inc. |
Kinase modulators and methods of use
|
|
PL1756084T3
(pl)
|
2004-06-04 |
2009-06-30 |
Arena Pharm Inc |
Podstawione pochodne arylowe i heteroarylowe jako modulatory metabolizmu oraz profilaktyka i leczenie zaburzeń z metabolizmem związanych
|
|
WO2005123677A1
(en)
|
2004-06-16 |
2005-12-29 |
Actelion Pharmaceuticals Ltd |
4-carbonyl substituted 1,1,2-trimethyl-1a,4,5,5a-tetrahydro-1h-4-aza-cyclopropa'a!pentalene derivatives as agonists for the g-protein-coupled receptor s1p1/edg1 and immunosuppressive agents
|
|
JP5315611B2
(ja)
|
2004-06-23 |
2013-10-16 |
小野薬品工業株式会社 |
Ｓ１ｐ受容体結合能を有する化合物およびその用途
|
|
US7781617B2
(en)
|
2004-07-16 |
2010-08-24 |
Kyorin Pharmaceutical Co., Ltd |
Effective use method of medicaments and method of preventing expression of side effect
|
|
JP2007284350A
(ja)
|
2004-07-27 |
2007-11-01 |
Takeda Chem Ind Ltd |
糖尿病治療剤
|
|
WO2006010379A1
(en)
|
2004-07-29 |
2006-02-02 |
Actelion Pharmaceuticals Ltd. |
Novel thiophene derivatives as immunosuppressive agents
|
|
TW200611687A
(en)
|
2004-07-29 |
2006-04-16 |
Sankyo Co |
Pharmaceutical compositions used for immunosuppressant
|
|
US8022225B2
(en)
|
2004-08-04 |
2011-09-20 |
Taisho Pharmaceutical Co., Ltd |
Triazole derivative
|
|
US20060223866A1
(en)
|
2004-08-13 |
2006-10-05 |
Praecis Pharmaceuticals, Inc. |
Methods and compositions for modulating sphingosine-1-phosphate (S1P) receptor activity
|
|
MX2007001661A
(es)
|
2004-08-13 |
2007-04-23 |
Praecis Pharm Inc |
Metodos y composiciones para modular la actividad del receptor de esfingosina -1 fosfato (sip).
|
|
EP1827438B2
(en)
|
2004-09-20 |
2014-12-10 |
Xenon Pharmaceuticals Inc. |
Piperazin derivatives for inhibiting human stearoyl-coa-desaturase
|
|
WO2006034337A2
(en)
|
2004-09-23 |
2006-03-30 |
Wyeth |
Carbazole and cyclopentaindole derivatives to treat infection with hepatitis c virus
|
|
JP4797021B2
(ja)
|
2004-10-01 |
2011-10-19 |
メルク・シャープ・エンド・ドーム・コーポレイション |
糖尿病の治療または予防用のジペプチジルペプチダ−ゼ−ｉｖ阻害剤としてのアミノピペリジン
|
|
US7557112B2
(en)
|
2004-10-08 |
2009-07-07 |
Astellas Pharma Inc. |
Aromatic-ring-fused pyrimidine derivative
|
|
CA2583947A1
(en)
|
2004-10-12 |
2006-04-20 |
Forbes Medi-Tech (Research) Inc. |
Compounds and methods of treating insulin resistance and cardiomyopathy
|
|
TW200621257A
(en)
|
2004-10-20 |
2006-07-01 |
Astellas Pharma Inc |
Pyrimidine derivative fused with nonaromatic ring
|
|
CA2583681A1
(en)
|
2004-10-22 |
2006-05-04 |
Merck & Co., Inc. |
2-(aryl)azacyclylmethyl carboxylates, sulfonates, phosphonates, phosphinates and heterocycles as s1p receptor agonists
|
|
PL1650186T3
(pl)
|
2004-10-22 |
2008-11-28 |
Bioprojet Soc Civ |
Nowe pochodne kwasów dikarboksylowych
|
|
AR051596A1
(es)
|
2004-10-26 |
2007-01-24 |
Irm Llc |
Compuestos heterociclicos condensados nitrogenados como inhibidores de la actividad del receptor canabinoide 1; composiciones farmaceuticas que los contienen y su empleo en la preparacion de medicamentos para el tratamiento de trastornos alimentarios
|
|
WO2006052566A2
(en)
|
2004-11-03 |
2006-05-18 |
Arena Pharmaceuticals, Inc. |
Gpr41 and modulators thereof for the treatment of insulin-related disorders
|
|
GB0425035D0
(en)
|
2004-11-12 |
2004-12-15 |
Novartis Ag |
Organic compounds
|
|
JP2008520692A
(ja)
|
2004-11-18 |
2008-06-19 |
ジ インスチチュート フォー ファーマシューティカル ディスカバリー、エルエルシー |
複素環置換カルボン酸
|
|
JPWO2006057448A1
(ja)
|
2004-11-26 |
2008-06-05 |
武田薬品工業株式会社 |
アリールアルカン酸誘導体
|
|
WO2006063033A2
(en)
|
2004-12-06 |
2006-06-15 |
University Of Virginia Patent Foundation |
Aryl amide sphingosine 1-phosphate analogs
|
|
BRPI0519006A2
(pt)
|
2004-12-13 |
2008-12-23 |
Daiichi Sankyo Co Ltd |
uso de um inibidor de fbpase, kit de uma composiÇço farmacÊutica, uso de uma preparaÇço de biguanida e um inibidor de fbpase, agente terapÊutico para diabetes melito, e, combinaÇço de agentes terapÊuticos
|
|
BRPI0519012A2
(pt)
|
2004-12-13 |
2008-12-23 |
Ono Pharmaceutical Co |
derivado do Ácido aminocarboxÍlico e seu uso medicinal
|
|
NZ556017A
(en)
|
2004-12-24 |
2009-10-30 |
Prosidion Ltd |
G-protein coupled receptor (gpr116) agonists and use thereof for treating obesity and diabetes
|
|
EP1838706A1
(en)
|
2004-12-24 |
2007-10-03 |
Prosidion Limited |
G-protein coupled receptor agonists
|
|
GB0428514D0
(en)
|
2004-12-31 |
2005-02-09 |
Prosidion Ltd |
Compounds
|
|
DOP2006000008A
(es)
|
2005-01-10 |
2006-08-31 |
Arena Pharm Inc |
Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1
|
|
DOP2006000010A
(es)
|
2005-01-10 |
2006-07-31 |
Arena Pharm Inc |
Procedimiento para preparar eteres aromáticos
|
|
MY148521A
(en)
|
2005-01-10 |
2013-04-30 |
Arena Pharm Inc |
Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
|
|
DOP2006000009A
(es)
|
2005-01-13 |
2006-08-15 |
Arena Pharm Inc |
Procedimiento para preparar eteres de pirazolo [3,4-d] pirimidina
|
|
WO2006078992A2
(en)
|
2005-01-19 |
2006-07-27 |
Neurogen Corporation |
Heteroaryl substituted piperazinyl-pyridine analogues
|
|
DE112005003337T5
(de)
|
2005-01-25 |
2008-02-21 |
Merck Patent Gmbh |
Mesogene Verbindungen, Flüssigkristallmedium und Flüssigkristallanzeige
|
|
US7754703B2
(en)
|
2005-02-14 |
2010-07-13 |
University Of Virginia Patent Foundation |
Cycloalkane-containing sphingosine 1-phosphate agonists
|
|
KR20080002850A
(ko)
|
2005-03-23 |
2008-01-04 |
액테리온 파마슈티칼 리미티드 |
신규한 티오펜 유도체
|
|
US7605269B2
(en)
|
2005-03-23 |
2009-10-20 |
Actelion Pharmaceuticals Ltd. |
Thiophene derivatives as Sphingosine-1-phosphate-1 receptor agonists
|
|
CA2602474C
(en)
|
2005-03-23 |
2014-06-10 |
Actelion Pharmaceuticals Ltd |
Hydrogenated benzo (c) thiophene derivatives as immunomodulators
|
|
WO2006131336A1
(en)
|
2005-06-08 |
2006-12-14 |
Novartis Ag |
POLYCYCLIC OXADIAZOLES OR I SOXAZOLES AND THEIR USE AS SlP RECEPTOR LIGANDS
|
|
US20090105136A1
(en)
|
2005-06-09 |
2009-04-23 |
Jun Suzuki |
NPY Y2 Agonist for Use as Therapeutic Agent for Disease Accompanied by Diarrhea
|
|
US7951794B2
(en)
|
2005-06-24 |
2011-05-31 |
Actelion Pharmaceuticals Ltd. |
Thiophene derivatives
|
|
TWI418350B
(zh)
|
2005-06-24 |
2013-12-11 |
Sankyo Co |
含有ｐｐａｒ調節劑之醫藥組成物的用途
|
|
JP2008545010A
(ja)
|
2005-06-30 |
2008-12-11 |
プロシディオン・リミテッド |
Ｇタンパク質共役受容体アゴニスト
|
|
JP5054004B2
(ja)
|
2005-07-01 |
2012-10-24 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
タンパク質キナーゼ阻害剤としてのピリミジン置換ベンゾイミダゾール誘導体
|
|
US20070060573A1
(en)
|
2005-08-10 |
2007-03-15 |
Lars Wortmann |
Acyltryptophanols
|
|
BRPI0615133A2
(pt)
|
2005-08-23 |
2011-05-03 |
Irm Llc |
compostos imunossupressores, composições farmacêuticas contendo os mesmos assim como referido uso
|
|
US20100160359A1
(en)
|
2005-09-16 |
2010-06-24 |
Arena Pharmaceuticals, Inc. |
Modulators of Metabolism and the Treatment of Disorders Related Thereto
|
|
TW200745055A
(en)
|
2005-09-23 |
2007-12-16 |
Organon Nv |
4-Phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives
|
|
JPWO2007037196A1
(ja)
|
2005-09-29 |
2009-04-09 |
山本化成株式会社 |
インドリン系化合物及びその製造方法
|
|
AR057894A1
(es)
|
2005-11-23 |
2007-12-26 |
Actelion Pharmaceuticals Ltd |
Derivados de tiofeno
|
|
EP1965807A4
(en)
|
2005-11-23 |
2010-10-27 |
Epix Delaware Inc |
S1P RECEPTOR MODULATING COMPOUNDS AND THEIR USE
|
|
CA2635531C
(en)
|
2005-12-29 |
2014-06-17 |
Lexicon Pharmaceutical Inc. |
Multicyclic amino acid derivatives and methods of their use
|
|
TWI404706B
(zh)
|
2006-01-11 |
2013-08-11 |
Actelion Pharmaceuticals Ltd |
新穎噻吩衍生物
|
|
TW200736234A
(en)
|
2006-01-17 |
2007-10-01 |
Astrazeneca Ab |
Chemical compounds
|
|
PL1973884T3
(pl)
|
2006-01-19 |
2017-05-31 |
Orchid Pharma Limited |
Nowe związki heterocykliczne
|
|
AU2007209051A1
(en)
|
2006-01-24 |
2007-08-02 |
Actelion Pharmaceuticals Ltd |
Novel pyridine derivatives
|
|
GB0601744D0
(en)
|
2006-01-27 |
2006-03-08 |
Novartis Ag |
Organic compounds
|
|
TWI389683B
(zh)
|
2006-02-06 |
2013-03-21 |
Kyorin Seiyaku Kk |
A therapeutic agent for an inflammatory bowel disease or an inflammatory bowel disease treatment using a 2-amino-1,3-propanediol derivative as an active ingredient
|
|
JP2009526073A
(ja)
|
2006-02-09 |
2009-07-16 |
ユニバーシティ オブ バージニア パテント ファンデーション |
二環式スフィンゴシン−１−リン酸受容体アナログ
|
|
TW200806611A
(en)
|
2006-02-09 |
2008-02-01 |
Daiichi Seiyaku Co |
Novel amidopropionic acid derivatives and medicine containing the same
|
|
US20070191371A1
(en)
|
2006-02-14 |
2007-08-16 |
Kalypsys, Inc. |
Heterocyclic modulators of ppar
|
|
AU2007214434B2
(en)
|
2006-02-15 |
2012-06-14 |
Allergan, Inc. |
Indole-3-carboxylic acid amide, ester, thioamide and thiol ester compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (S1P) receptor antagonist biological activity
|
|
CN101460458A
(zh)
|
2006-02-15 |
2009-06-17 |
阿勒根公司 |
具有1－磷酸－鞘氨醇(s1p)受体拮抗剂生物活性的带芳基或者杂芳基基团的吲哚－3－羧酸的酰胺、酯、硫代酰胺和硫羟酸酯化合物
|
|
KR20080096780A
(ko)
|
2006-02-21 |
2008-11-03 |
유니버시티 오브 버지니아 페이턴트 파운데이션 |
Ｓ１ｐ 수용체 효능제로서의 페닐-시클로알킬 및 페닐-헤테로시클릭 유도체
|
|
US7649098B2
(en)
|
2006-02-24 |
2010-01-19 |
Lexicon Pharmaceuticals, Inc. |
Imidazole-based compounds, compositions comprising them and methods of their use
|
|
MX2008011615A
(es)
|
2006-03-14 |
2008-09-22 |
Amgen Inc |
Derivados de acidos carboxilicos biciclicos utiles para tratar trastornos metabolicos.
|
|
AU2007227274A1
(en)
|
2006-03-21 |
2007-09-27 |
Epix Delaware, Inc. |
S1P receptor modulating compounds
|
|
JP2007262009A
(ja)
|
2006-03-29 |
2007-10-11 |
Dai Ichi Seiyaku Co Ltd |
ヘテロアリール低級カルボン酸誘導体
|
|
PL2003132T3
(pl)
|
2006-04-03 |
2014-10-31 |
Astellas Pharma Inc |
Pochodne oksadiazolu jako agoniści S1P1
|
|
PE20071221A1
(es)
|
2006-04-11 |
2007-12-14 |
Arena Pharm Inc |
Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas
|
|
US7833730B2
(en)
|
2006-04-11 |
2010-11-16 |
Arena Pharmaceuticals, Inc. |
Methods of using GPR119 to identify compounds useful for increasing bone mass in an individual
|
|
GB0607389D0
(en)
|
2006-04-12 |
2006-05-24 |
Novartis Ag |
Organic compounds
|
|
WO2007129745A1
(ja)
|
2006-05-09 |
2007-11-15 |
Daiichi Sankyo Company, Limited |
ヘテロアリールアミド低級カルボン酸誘導体
|
|
EP2258700A1
(en)
|
2006-05-09 |
2010-12-08 |
Pfizer Products Inc. |
Cycloalkylamino acid derivatives and pharmaceutical compositions thereof
|
|
WO2007129473A1
(ja)
|
2006-05-09 |
2007-11-15 |
Daiichi Sankyo Company, Limited |
二環性アリール誘導体
|
|
TW200811147A
(en)
|
2006-07-06 |
2008-03-01 |
Arena Pharm Inc |
Modulators of metabolism and the treatment of disorders related thereto
|
|
TW200811140A
(en)
|
2006-07-06 |
2008-03-01 |
Arena Pharm Inc |
Modulators of metabolism and the treatment of disorders related thereto
|
|
EP2043744A2
(en)
|
2006-07-13 |
2009-04-08 |
SmithKline Beecham Corporation |
Chemical compounds
|
|
AR062156A1
(es)
|
2006-08-01 |
2008-10-22 |
Praecis Pharm Inc |
Compuestos agonistas y selectivos del receptor s1p-1
|
|
EP2046766A1
(en)
|
2006-08-01 |
2009-04-15 |
Praecis Pharmaceuticals Incorporated |
Agonists of the sphingosine- 1- phosphate receptor (slp)
|
|
JP2009545630A
(ja)
|
2006-08-04 |
2009-12-24 |
プリーシス・ファーマシューティカルズ・インコーポレイテッド |
化合物
|
|
CA2659598A1
(en)
|
2006-08-08 |
2008-02-14 |
Kyorin Pharmaceutical Co., Ltd. |
Amino phosphate derivative and s1p receptor modulator having same as an active ingredient
|
|
EP2054377A1
(en)
|
2006-08-24 |
2009-05-06 |
Praecis Pharmaceuticals Incorporated |
Chemical compounds
|
|
JP2009269819A
(ja)
|
2006-08-25 |
2009-11-19 |
Asahi Kasei Pharma Kk |
アミン化合物
|
|
WO2008025799A1
(en)
|
2006-08-30 |
2008-03-06 |
Biovitrum Ab (Publ) |
Pyridazine compounds for treating gpr119 related disorders
|
|
CA2662852A1
(en)
|
2006-09-07 |
2008-03-13 |
Allergan, Inc. |
Heteroaromatic compounds having sphingosine-1-phosphate (s1p) receptor agonist and/or antagonist biological activity
|
|
PT2069336E
(pt)
|
2006-09-07 |
2013-03-07 |
Actelion Pharmaceuticals Ltd |
Derivados de piridin-4-ilo como agentes imunomoduladores
|
|
AR061841A1
(es)
|
2006-09-07 |
2008-09-24 |
Actelion Pharmaceuticals Ltd |
Derivados de tiofen-oxadiazoles, agonistas del receptor s1p1/edg1, composiciones farmaceuticas que los contienen y usos como agentes inmunomoduladores.
|
|
KR20090060333A
(ko)
|
2006-09-08 |
2009-06-11 |
노파르티스 아게 |
림프구 상호작용에 의해 매개되는 질환의 치료에 유용한 ｎ-바이아릴 (헤테로)아릴술폰아미드 유도체
|
|
ES2393412T3
(es)
|
2006-09-21 |
2012-12-21 |
Actelion Pharmaceuticals Ltd. |
Derivados de fenilo y su uso como inmunomoduladores
|
|
JP5330260B2
(ja)
|
2006-12-06 |
2013-10-30 |
スミスクライン ビーチャム コーポレーション |
二環式化合物ならびに抗糖尿病薬としての使用
|
|
AU2007334519A1
(en)
|
2006-12-14 |
2008-06-26 |
Merck Sharp & Dohme Corp. |
Acyl bipiperidinyl compounds, compositions containing such compounds and methods of treatment
|
|
EP2109364A4
(en)
|
2006-12-15 |
2010-04-14 |
Abbott Lab |
NOVEL OXADIAZONE COMPOUNDS
|
|
JO2701B1
(en)
|
2006-12-21 |
2013-03-03 |
جلاكسو جروب ليميتد |
Vehicles
|
|
BRPI0720478A2
(pt)
|
2006-12-21 |
2014-01-14 |
Abbott Laboratoires |
Compostos agonistas e antagonistas do receptor esfingosina-1-fosfato
|
|
GB0625648D0
(en)
|
2006-12-21 |
2007-01-31 |
Glaxo Group Ltd |
Compounds
|
|
MX2009007334A
(es)
|
2007-01-11 |
2009-07-15 |
Allergan Inc |
Compuestos de amida del acido indol-3-carboxilico 6-substituido que tienen actividad antagonista biologica del receptor esfingosina-1-fosfato (s1p).
|
|
WO2008091967A1
(en)
|
2007-01-26 |
2008-07-31 |
Smithkline Beecham Corporation |
Chemical compounds
|
|
WO2008097819A2
(en)
|
2007-02-05 |
2008-08-14 |
Smithkline Beecham Corporation |
Chemical compounds
|
|
BRPI0808789A2
(pt)
|
2007-03-16 |
2014-08-12 |
Actelion Pharmaceuticals Ltd |
Compostos e composição farmacêutica de derivados aminopiridina e uso destes
|
|
JP5191497B2
(ja)
|
2007-03-21 |
2013-05-08 |
エピックス ファーマシューティカルズ，インコーポレイテッド |
Ｓ１ｐ受容体調節化合物およびその使用
|
|
WO2008128832A1
(en)
|
2007-04-18 |
2008-10-30 |
Nicox S.A. |
Nitroderivatives of non-peptidic renin inhibitors for the treatment of cardiovascular, renal and chronic liver disease, inflammations and metabolic syndrome
|
|
AU2008240773B2
(en)
|
2007-04-19 |
2013-10-03 |
Glaxo Group Limited |
Oxadiazole substituted indazole derivatives for use as sphingosine 1-phosphate (S1P) agonists
|
|
US7910583B2
(en)
|
2007-05-04 |
2011-03-22 |
Bristol-Myers Squibb Company |
[6,6] and [6,7]-bicyclic GPR119 G protein-coupled receptor agonists
|
|
EP2014653A1
(en)
|
2007-06-15 |
2009-01-14 |
Bioprojet |
Novel dicarboxylic acid derivatives as S1P1 receptor agonists
|
|
WO2009011850A2
(en)
|
2007-07-16 |
2009-01-22 |
Abbott Laboratories |
Novel therapeutic compounds
|
|
WO2009019506A1
(en)
|
2007-08-03 |
2009-02-12 |
Astrazeneca Ab |
Heterocyclyc sulfonamides having edg-1 antagonistic activity
|
|
CN101790519B
(zh)
|
2007-08-08 |
2013-10-16 |
默克雪兰诺有限公司 |
用于治疗多发性硬化症的结合于鞘氨醇1-磷酸(s1p)的6-氨基-嘧啶-4-羧酰胺衍生物及相关化合物
|
|
BRPI0817211A2
(pt)
|
2007-09-20 |
2017-05-16 |
Irm Llc |
composto composições como moduladores da atividade de gpr119
|
|
TW200930368A
(en)
|
2007-11-15 |
2009-07-16 |
Astrazeneca Ab |
Bis-(sulfonylamino) derivatives in therapy
|
|
EP2222668B1
(en)
|
2007-12-18 |
2011-11-02 |
Arena Pharmaceuticals, Inc. |
Tetrahydrocyclopenta[b]indol-3-yl carboxylic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
|
|
EP2252615A1
(en)
|
2008-01-25 |
2010-11-24 |
Arena Pharmaceuticals, Inc. |
Dihydro- 1h- pyrrolo [1,2-a]indol-1-yl carboxylic derivatives which act as s1p1 agonists
|
|
AR070398A1
(es)
|
2008-02-22 |
2010-03-31 |
Gruenenthal Chemie |
Derivados sustituidos de indol
|
|
PL2278960T5
(pl)
*
|
2008-03-17 |
2020-06-29 |
Actelion Pharmaceuticals Ltd. |
Schemat dawkowania dla selektywnego agonisty receptora sip1
|
|
WO2009125434A2
(en)
|
2008-04-07 |
2009-10-15 |
Cadila Healthcare Limited |
Oxime derivatives
|
|
EP2271619A1
(en)
|
2008-04-07 |
2011-01-12 |
Irm Llc |
Compounds and compositions as modulators of gpr119 activity
|
|
EP2108960A1
(en)
|
2008-04-07 |
2009-10-14 |
Arena Pharmaceuticals, Inc. |
Methods of using A G protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditons modulated by PYY
|
|
EP3782991A1
(en)
|
2008-05-14 |
2021-02-24 |
The Scripps Research Institute |
Novel modulators of sphingosine phosphate receptors
|
|
WO2009151621A1
(en)
|
2008-06-13 |
2009-12-17 |
Arena Pharmaceuticals, Inc. |
Substituted (1, 2, 4-0xadiaz0l-3-yl) indolin-1-yl carboxylic acid derivatives useful as s1p1 agonists
|
|
WO2009151626A1
(en)
|
2008-06-13 |
2009-12-17 |
Arena Pharmaceuticals, Inc. |
Substituted (1, 2, 4-0xadiaz0l-3-yl) indolin-1-yl carboxylic acid derivatives useful as s1p1 agonists
|
|
US8580841B2
(en)
|
2008-07-23 |
2013-11-12 |
Arena Pharmaceuticals, Inc. |
Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
|
|
HRP20160890T1
(hr)
*
|
2008-08-27 |
2016-09-23 |
Arena Pharmaceuticals, Inc. |
Derivati supstituirane tricikličke kiseline kao agonisti s1p1-receptora korisni u liječenju autoimunih i upalnih poremećaja
|
|
JP5657565B2
(ja)
*
|
2008-12-22 |
2015-01-21 |
ノバルティス アーゲー |
Ｓ１ｐ受容体アゴニストの投与レジメン
|
|
TW201028143A
(en)
*
|
2008-12-22 |
2010-08-01 |
Novartis Ag |
Dosage regimen for a S1P receptor agonist
|
|
CA2747809A1
(en)
|
2008-12-23 |
2010-07-01 |
Joel M. Harris |
Bicyclic heterocycle derivatives and methods of use thereof
|
|
WO2010075273A1
(en)
|
2008-12-23 |
2010-07-01 |
Schering Corporation |
Bicyclic heterocycle derivatives and methods of use thereof
|
|
WO2010074271A1
(ja)
|
2008-12-26 |
2010-07-01 |
武田薬品工業株式会社 |
糖尿病治療剤
|
|
US20120016119A1
(en)
|
2009-01-22 |
2012-01-19 |
Yasunori Tsuboi |
NOVEL PYRROLO(2,3-d)PYRIMIDINE COMPOUND
|
|
PE20120578A1
(es)
|
2009-02-10 |
2012-06-17 |
Abbott Lab |
Agonistas y antagonistas del receptor de s1p5, y metodos de uso de los mismos
|
|
WO2011005290A1
(en)
|
2009-06-23 |
2011-01-13 |
Arena Pharmaceuticals, Inc. |
Disubstituted oxadiazole derivatives useful in the treatment of autoimmune and inflammatory disorders
|
|
WO2011005295A1
(en)
|
2009-06-24 |
2011-01-13 |
Arena Pharmaceuticals, Inc. |
Modulators of the sphingosine-1-phosphate (s1p) receptor useful for the treatment of disorders related thereto
|
|
AR077642A1
(es)
|
2009-07-09 |
2011-09-14 |
Arena Pharm Inc |
Moduladores del metabolismo y el tratamiento de trastornos relacionados con el mismo
|
|
AR077638A1
(es)
|
2009-07-15 |
2011-09-14 |
Lilly Co Eli |
Compuesto de (metanosulfonil -piperidin )-( alcoxi-aril) -tetrahidro- piridina , composicion farmaceutica que lo comprende y su uso para preparar un medicamento util para el tratamiento de diabetes u obesidad
|
|
WO2011030139A1
(en)
|
2009-09-11 |
2011-03-17 |
Astrazeneca Ab |
4- (pyrimidin-2-yl) -piperazine and 4- (pyrimidin-2-yl) -piperidine derivatives as gpr119 modulators
|
|
US9216972B2
(en)
|
2009-10-29 |
2015-12-22 |
Bristol-Myers Squibb Company |
Tricyclic heterocyclic compounds
|
|
US8440693B2
(en)
|
2009-12-22 |
2013-05-14 |
Novartis Ag |
Substituted isoquinolinones and quinazolinones
|
|
JP5856980B2
(ja)
|
2010-01-27 |
2016-02-10 |
アリーナ ファーマシューティカルズ， インコーポレイテッド |
（Ｒ）−２−（７−（４−シクロペンチル−３−（トリフルオロメチル）ベンジルオキシ）−１，２，３，４−テトラヒドロシクロペンタ［ｂ］インドール−３−イル）酢酸およびその塩の調製のためのプロセス
|
|
CN105503882B
(zh)
|
2010-03-03 |
2019-07-05 |
艾尼纳制药公司 |
制备s1p1受体调节剂及其晶体形式的方法
|
|
CA2795513A1
(en)
|
2010-04-06 |
2011-10-13 |
Arena Pharmaceuticals, Inc. |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
|
JP2013533286A
(ja)
|
2010-07-30 |
2013-08-22 |
セントルイス ユニバーシティ |
疼痛を治療する方法
|
|
EP3323818A1
(en)
|
2010-09-22 |
2018-05-23 |
Arena Pharmaceuticals, Inc. |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
|
EA034451B1
(ru)
|
2011-02-07 |
2020-02-10 |
Байоджен Ма Инк. |
Модуляторы s1p
|
|
US20140018371A1
(en)
|
2011-04-01 |
2014-01-16 |
Arena Pharmaceuticals, Inc. |
Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
|
|
WO2012145361A1
(en)
|
2011-04-19 |
2012-10-26 |
Arena Pharmaceuticals, Inc. |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
|
US20140051714A1
(en)
|
2011-04-22 |
2014-02-20 |
Arena Pharmaceuticals, Inc. |
Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
|
|
US20140038889A1
(en)
|
2011-04-22 |
2014-02-06 |
Arena Pharmaceuticals, Inc. |
Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
|
|
WO2012170702A1
(en)
|
2011-06-08 |
2012-12-13 |
Arena Pharmaceuticals, Inc. |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
|
WO2013055910A1
(en)
|
2011-10-12 |
2013-04-18 |
Arena Pharmaceuticals, Inc. |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
|
KR101889131B1
(ko)
|
2011-12-23 |
2018-09-20 |
메이지 세이카 파루마 가부시키가이샤 |
신규 s1p 수용체 조정제
|
|
BR112015020140A8
(pt)
|
2013-04-04 |
2019-11-19 |
Novartis Ag |
ácido 1-{4-[1-(4-ciclo-hexil-3-trifluorometil-benziloxi-imino)-etil]-2-etil-benzil}-azetidina-3-carboxílico, seus usos e combinação farmacêutica
|
|
PL3242666T3
(pl)
|
2015-01-06 |
2025-02-17 |
Arena Pharmaceuticals, Inc. |
Związek do zastosowania w leczeniu dolegliwości związanych z receptorem s1p1
|
|
BR112017027656B1
(pt)
|
2015-06-22 |
2023-12-05 |
Arena Pharmaceuticals, Inc. |
Hábito cristalino de placa livre de sal de l-arginina de ácido (r)-2-(7-(4- ciclopentil-3-(trifluorometil)benzilóxi)- 1,2,3,4-tetra-hidrociclo-penta[b]indol-3- il)acético, composição farmacêutica que o compreende, seus usos e método de preparação do mesmo
|
|
MX2019009841A
(es)
|
2017-02-16 |
2020-01-30 |
Arena Pharm Inc |
Compuestos y metodos para el tratamiento de la colangitis biliar primaria.
|
|
MX2019009843A
(es)
|
2017-02-16 |
2020-01-30 |
Arena Pharm Inc |
Compuestos y metodos para el tratamiento de la enfermedad inflamatoria intestinal con manifestaciones extraintestinales.
|
|
CA3102136A1
(en)
|
2018-06-06 |
2019-12-12 |
Arena Pharmaceuticals, Inc. |
Methods of treating conditions related to the s1p1 receptor
|
|
JP7265620B2
(ja)
|
2018-10-03 |
2023-04-26 |
アリーナ ファーマシューティカルズ， インコーポレイテッド |
強皮症の治療のための方法
|
|
CN118649163A
(zh)
|
2018-11-30 |
2024-09-17 |
艾尼纳制药公司 |
治疗与s1p1受体有关的病况的方法
|
|
CN113874009A
(zh)
|
2019-01-08 |
2021-12-31 |
艾尼纳制药公司 |
治疗与s1p1受体有关的病况的方法
|